(Q34541180)

2 August 2017

title

Genomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivo (English)

1 reference

2 August 2017

1 reference

Denise Elizabeth McCormack

1

1 reference

2 August 2017

Patrick Mannal

2

1 reference

2 August 2017

Debbie McDonald

3

1 reference

2 August 2017

Scott Tighe

4

1 reference

2 August 2017

Joshua Hanson

5

1 reference

2 August 2017

David McFadden

6

1 reference

2 August 2017

language of work or name

1 reference

27 March 2012

1 reference

Journal of Gastrointestinal Surgery

2 August 2017

published in

1 reference

2 August 2017

volume

16

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

1136-1143

1 reference

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Pterostilbene inhibits pancreatic cancer in vitro

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Pharmacometrics of stilbenes: seguing towards the clinic.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Resveratrol: a review of preclinical studies for human cancer prevention

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Apoptosis: targets in pancreatic cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237162

Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11605-012-1869-7

Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11605-012-1869-7

Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11605-012-1869-7

Changes in the phytoalexin content of various Vitis spp. in response to ultraviolet C elicitation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22450950

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22450950

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22450950

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11605-012-1869-7

1 reference

2 August 2017

1 reference

2 August 2017

1 reference